Articles tagged ‘’

Women with atrial fibrillation (AF) have a moderately increased risk of stroke compared with men, suggesting that female gender should be considered when making decisions about anti-clotting treatment, according to a study¹ by Scandinavian workers (pictured) published recently on bmj.com.

Millions of people suffering from pre-diabetes may be at a higher risk of stroke, according to a study published recently on bmj.com.¹

BMI The London Independent Hospital’s cardiology team announced recently that it has become the first UK hospital to routinely use an all-in-one genetic test (Spartan RX) to identify patients who are resistant to clopidogrel.

SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnoea (CSA) improves survival and outcomes of patients with stable heart failure, has enrolled its 1,000th participant. The study, which began in 2008, has a target of approximately 1,250 participants.

The incidence of infective endocarditis among dental patients did not increase after new guidelines called for giving preventive antibiotics before dental procedures only to those at greatest risk of complications, according to independent research published in Circulation.¹

Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a study¹ reported in Circulation.

Dr Mark Temple, the Royal College of Physicians’ (RCP) acute medicine fellow, has welcomed the publication of the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report ‘Time to Intervene’,¹ which highlights the importance of early consultant review of patients admitted acutely to hospital.

Text message prompts can help patients living with long term conditions (LTCs) stick to their treatment programmes in the short term, according to a review¹ of the available evidence published online recently in the Journal of the American Medical Informatics Association.

Three approaches may reverse the activity of the new oral anticoagulant apixaban, when a person needs emergency surgery, for example, according to laboratory research presented in the American Heart Association’s Emerging Science Series webinar.¹

This year’s Heart Rhythm Congress (HRC), an annual event organised by Arrhythmia Alliance, The Heart Rhythm Charity, in partnership with Heart Rhythm UK, will be held from 23rd–26th September.